HEADER TRANSCRIPTION 19-JUN-12 4FN6 TITLE STRUCTURAL CHARACTERIZATION OF THIAMINASE TYPE II TENA FROM TITLE 2 STAPHYLOCOCCUS AUREUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: THIAMINASE-2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: THIAMINASE II; COMPND 5 EC: 3.5.99.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 282458; SOURCE 4 STRAIN: MRSA252; SOURCE 5 GENE: TENA, SAR2183; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BLR (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS ALPHA-HELIX, THIAMINASE, VITAMIN B1, BI-FUNCTIONAL ENZYME, CLEAVAGE KEYWDS 2 OF THIAMINE INTO HMP AND THZ, DEAMINATION OF AMINO-PYRIMIDINE TO HMP KEYWDS 3 IN S.AUREUS, HYDROLASE, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR A.BEGUM,J.DREBES,M.PERBANDT,C.WRENGER,C.BETZEL REVDAT 3 16-OCT-24 4FN6 1 REMARK REVDAT 2 13-SEP-23 4FN6 1 REMARK LINK REVDAT 1 19-DEC-12 4FN6 0 JRNL AUTH A.BEGUM,J.DREBES,M.PERBANDT,C.WRENGER,C.BETZEL JRNL TITL STRUCTURAL CHARACTERIZATION OF THIAMINASE TYPE II TENA FROM JRNL TITL 2 STAPHYLOCOCCUS AUREUS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.2_869) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.87 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 3 NUMBER OF REFLECTIONS : 31701 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.320 REMARK 3 FREE R VALUE TEST SET COUNT : 2002 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.8736 - 6.4625 0.91 2161 146 0.1817 0.2364 REMARK 3 2 6.4625 - 5.1380 0.93 2112 154 0.2124 0.2285 REMARK 3 3 5.1380 - 4.4910 0.94 2116 142 0.1632 0.1934 REMARK 3 4 4.4910 - 4.0815 0.94 2120 132 0.1720 0.2252 REMARK 3 5 4.0815 - 3.7895 0.95 2112 156 0.1982 0.2517 REMARK 3 6 3.7895 - 3.5665 0.96 2121 142 0.2110 0.3091 REMARK 3 7 3.5665 - 3.3881 0.95 2130 141 0.2220 0.2647 REMARK 3 8 3.3881 - 3.2408 0.96 2119 151 0.2329 0.2405 REMARK 3 9 3.2408 - 3.1162 0.96 2141 137 0.2441 0.2588 REMARK 3 10 3.1162 - 3.0088 0.96 2130 131 0.2696 0.3253 REMARK 3 11 3.0088 - 2.9148 0.97 2125 147 0.3064 0.3369 REMARK 3 12 2.9148 - 2.8315 0.97 2134 135 0.2943 0.3332 REMARK 3 13 2.8315 - 2.7570 0.97 2132 152 0.3015 0.3684 REMARK 3 14 2.7570 - 2.6898 0.94 2046 136 0.3308 0.4108 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.98 REMARK 3 K_SOL : 0.30 REMARK 3 B_SOL : 30.77 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.760 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.820 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.89010 REMARK 3 B22 (A**2) : -7.24550 REMARK 3 B33 (A**2) : 0.35540 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 7681 REMARK 3 ANGLE : 1.223 10342 REMARK 3 CHIRALITY : 0.082 1089 REMARK 3 PLANARITY : 0.005 1331 REMARK 3 DIHEDRAL : 19.546 2871 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -1.2018 18.8541 -25.8506 REMARK 3 T TENSOR REMARK 3 T11: 0.2060 T22: 0.1733 REMARK 3 T33: 0.2292 T12: -0.0201 REMARK 3 T13: -0.0012 T23: -0.0207 REMARK 3 L TENSOR REMARK 3 L11: 0.4203 L22: 0.3501 REMARK 3 L33: 0.4262 L12: -0.1240 REMARK 3 L13: -0.2844 L23: 0.0988 REMARK 3 S TENSOR REMARK 3 S11: 0.0037 S12: -0.0051 S13: 0.0004 REMARK 3 S21: 0.0134 S22: -0.0595 S23: 0.1476 REMARK 3 S31: 0.0393 S32: 0.0059 S33: -0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4FN6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUN-12. REMARK 100 THE DEPOSITION ID IS D_1000073108. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8123 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31741 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.690 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 3.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3NO6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28%(W/V) PEG 3500, 0.2 M SODIUM REMARK 280 ACETATE AND 0.1 M TRIS HCL BUFFER PH 8.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 51.63800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.72550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.03050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.72550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 51.63800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.03050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 37970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -60.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 226 REMARK 465 VAL A 227 REMARK 465 ASN A 228 REMARK 465 ASP A 229 REMARK 465 LYS B 226 REMARK 465 VAL B 227 REMARK 465 ASN B 228 REMARK 465 ASP B 229 REMARK 465 GLY C 225 REMARK 465 LYS C 226 REMARK 465 VAL C 227 REMARK 465 ASN C 228 REMARK 465 ASP C 229 REMARK 465 LYS D 226 REMARK 465 VAL D 227 REMARK 465 ASN D 228 REMARK 465 ASP D 229 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 69 CG CD CE NZ REMARK 480 LYS B 69 CG CD CE NZ REMARK 480 GLU B 73 CG CD OE1 OE2 REMARK 480 GLN B 91 CG CD OE1 NE2 REMARK 480 GLU B 157 CG CD OE1 OE2 REMARK 480 GLN B 196 CG CD OE1 NE2 REMARK 480 LYS C 49 CD CE NZ REMARK 480 LYS C 69 CD CE NZ REMARK 480 GLU C 82 C CB CG CD OE1 OE2 REMARK 480 LEU C 84 CG CD1 CD2 REMARK 480 GLN C 91 CG CD OE1 NE2 REMARK 480 HIS C 152 CD2 REMARK 480 LYS C 162 CD CE NZ REMARK 480 LYS C 184 CD CE NZ REMARK 480 LYS C 192 CG CD CE NZ REMARK 480 LYS D 49 CG CD CE NZ REMARK 480 LYS D 153 CG CD CE NZ REMARK 480 ARG D 156 CG CD NE CZ NH1 NH2 REMARK 480 LYS D 158 CG CD CE NZ REMARK 480 LYS D 162 CE NZ REMARK 480 ASP D 172 CG OD1 OD2 REMARK 480 LYS D 192 CG CD CE NZ REMARK 480 MET D 216 CB CG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 188 O HOH A 415 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 138 C - N - CD ANGL. DEV. = -18.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 82 73.70 56.98 REMARK 500 PRO B 136 14.15 -69.14 REMARK 500 THR B 169 -59.31 -129.23 REMARK 500 THR C 169 -58.79 -129.36 REMARK 500 ASN D 63 -69.22 -130.30 REMARK 500 PRO D 136 -4.55 -45.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT C 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT C 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT D 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT D 303 DBREF 4FN6 A 1 229 UNP Q6GEY1 TENA_STAAR 1 229 DBREF 4FN6 B 1 229 UNP Q6GEY1 TENA_STAAR 1 229 DBREF 4FN6 C 1 229 UNP Q6GEY1 TENA_STAAR 1 229 DBREF 4FN6 D 1 229 UNP Q6GEY1 TENA_STAAR 1 229 SEQRES 1 A 229 MET GLU PHE SER GLN LYS LEU TYR GLN ALA ALA LYS PRO SEQRES 2 A 229 ILE ILE ASN ASP ILE TYR GLU ASP ASP PHE ILE GLN LYS SEQRES 3 A 229 MET LEU LEU GLY ASN ILE GLN ALA ASP ALA LEU ARG HIS SEQRES 4 A 229 TYR LEU GLN ALA ASP ALA ALA TYR LEU LYS GLU PHE THR SEQRES 5 A 229 ASN LEU TYR ALA LEU LEU ILE PRO LYS MET ASN SER MET SEQRES 6 A 229 ASN ASP VAL LYS PHE LEU VAL GLU GLN ILE GLU PHE MET SEQRES 7 A 229 VAL GLU GLY GLU VAL LEU ALA HIS ASP ILE LEU ALA GLN SEQRES 8 A 229 ILE VAL GLY GLU SER TYR GLU GLU ILE ILE LYS THR LYS SEQRES 9 A 229 VAL TRP PRO PRO SER GLY ASP HIS TYR ILE LYS HIS MET SEQRES 10 A 229 TYR PHE GLN ALA HIS SER ARG GLU ASN ALA ILE TYR THR SEQRES 11 A 229 ILE ALA ALA MET ALA PRO CME PRO TYR ILE TYR ALA GLU SEQRES 12 A 229 LEU ALA LYS ARG SER GLN SER ASP HIS LYS LEU ASN ARG SEQRES 13 A 229 GLU LYS ASP THR ALA LYS TRP PHE ASP PHE TYR SER THR SEQRES 14 A 229 GLU MET ASP ASP ILE ILE ASN VAL PHE GLU SER LEU MET SEQRES 15 A 229 ASN LYS LEU ALA GLU SER MET SER ASP LYS GLU LEU GLU SEQRES 16 A 229 GLN VAL LYS GLN VAL PHE LEU GLU SER CYS ILE HIS GLU SEQRES 17 A 229 ARG ARG PHE PHE ASN MET ALA MET THR LEU GLU GLN TRP SEQRES 18 A 229 GLU PHE GLY GLY LYS VAL ASN ASP SEQRES 1 B 229 MET GLU PHE SER GLN LYS LEU TYR GLN ALA ALA LYS PRO SEQRES 2 B 229 ILE ILE ASN ASP ILE TYR GLU ASP ASP PHE ILE GLN LYS SEQRES 3 B 229 MET LEU LEU GLY ASN ILE GLN ALA ASP ALA LEU ARG HIS SEQRES 4 B 229 TYR LEU GLN ALA ASP ALA ALA TYR LEU LYS GLU PHE THR SEQRES 5 B 229 ASN LEU TYR ALA LEU LEU ILE PRO LYS MET ASN SER MET SEQRES 6 B 229 ASN ASP VAL LYS PHE LEU VAL GLU GLN ILE GLU PHE MET SEQRES 7 B 229 VAL GLU GLY GLU VAL LEU ALA HIS ASP ILE LEU ALA GLN SEQRES 8 B 229 ILE VAL GLY GLU SER TYR GLU GLU ILE ILE LYS THR LYS SEQRES 9 B 229 VAL TRP PRO PRO SER GLY ASP HIS TYR ILE LYS HIS MET SEQRES 10 B 229 TYR PHE GLN ALA HIS SER ARG GLU ASN ALA ILE TYR THR SEQRES 11 B 229 ILE ALA ALA MET ALA PRO CME PRO TYR ILE TYR ALA GLU SEQRES 12 B 229 LEU ALA LYS ARG SER GLN SER ASP HIS LYS LEU ASN ARG SEQRES 13 B 229 GLU LYS ASP THR ALA LYS TRP PHE ASP PHE TYR SER THR SEQRES 14 B 229 GLU MET ASP ASP ILE ILE ASN VAL PHE GLU SER LEU MET SEQRES 15 B 229 ASN LYS LEU ALA GLU SER MET SER ASP LYS GLU LEU GLU SEQRES 16 B 229 GLN VAL LYS GLN VAL PHE LEU GLU SER CYS ILE HIS GLU SEQRES 17 B 229 ARG ARG PHE PHE ASN MET ALA MET THR LEU GLU GLN TRP SEQRES 18 B 229 GLU PHE GLY GLY LYS VAL ASN ASP SEQRES 1 C 229 MET GLU PHE SER GLN LYS LEU TYR GLN ALA ALA LYS PRO SEQRES 2 C 229 ILE ILE ASN ASP ILE TYR GLU ASP ASP PHE ILE GLN LYS SEQRES 3 C 229 MET LEU LEU GLY ASN ILE GLN ALA ASP ALA LEU ARG HIS SEQRES 4 C 229 TYR LEU GLN ALA ASP ALA ALA TYR LEU LYS GLU PHE THR SEQRES 5 C 229 ASN LEU TYR ALA LEU LEU ILE PRO LYS MET ASN SER MET SEQRES 6 C 229 ASN ASP VAL LYS PHE LEU VAL GLU GLN ILE GLU PHE MET SEQRES 7 C 229 VAL GLU GLY GLU VAL LEU ALA HIS ASP ILE LEU ALA GLN SEQRES 8 C 229 ILE VAL GLY GLU SER TYR GLU GLU ILE ILE LYS THR LYS SEQRES 9 C 229 VAL TRP PRO PRO SER GLY ASP HIS TYR ILE LYS HIS MET SEQRES 10 C 229 TYR PHE GLN ALA HIS SER ARG GLU ASN ALA ILE TYR THR SEQRES 11 C 229 ILE ALA ALA MET ALA PRO CME PRO TYR ILE TYR ALA GLU SEQRES 12 C 229 LEU ALA LYS ARG SER GLN SER ASP HIS LYS LEU ASN ARG SEQRES 13 C 229 GLU LYS ASP THR ALA LYS TRP PHE ASP PHE TYR SER THR SEQRES 14 C 229 GLU MET ASP ASP ILE ILE ASN VAL PHE GLU SER LEU MET SEQRES 15 C 229 ASN LYS LEU ALA GLU SER MET SER ASP LYS GLU LEU GLU SEQRES 16 C 229 GLN VAL LYS GLN VAL PHE LEU GLU SER CYS ILE HIS GLU SEQRES 17 C 229 ARG ARG PHE PHE ASN MET ALA MET THR LEU GLU GLN TRP SEQRES 18 C 229 GLU PHE GLY GLY LYS VAL ASN ASP SEQRES 1 D 229 MET GLU PHE SER GLN LYS LEU TYR GLN ALA ALA LYS PRO SEQRES 2 D 229 ILE ILE ASN ASP ILE TYR GLU ASP ASP PHE ILE GLN LYS SEQRES 3 D 229 MET LEU LEU GLY ASN ILE GLN ALA ASP ALA LEU ARG HIS SEQRES 4 D 229 TYR LEU GLN ALA ASP ALA ALA TYR LEU LYS GLU PHE THR SEQRES 5 D 229 ASN LEU TYR ALA LEU LEU ILE PRO LYS MET ASN SER MET SEQRES 6 D 229 ASN ASP VAL LYS PHE LEU VAL GLU GLN ILE GLU PHE MET SEQRES 7 D 229 VAL GLU GLY GLU VAL LEU ALA HIS ASP ILE LEU ALA GLN SEQRES 8 D 229 ILE VAL GLY GLU SER TYR GLU GLU ILE ILE LYS THR LYS SEQRES 9 D 229 VAL TRP PRO PRO SER GLY ASP HIS TYR ILE LYS HIS MET SEQRES 10 D 229 TYR PHE GLN ALA HIS SER ARG GLU ASN ALA ILE TYR THR SEQRES 11 D 229 ILE ALA ALA MET ALA PRO CME PRO TYR ILE TYR ALA GLU SEQRES 12 D 229 LEU ALA LYS ARG SER GLN SER ASP HIS LYS LEU ASN ARG SEQRES 13 D 229 GLU LYS ASP THR ALA LYS TRP PHE ASP PHE TYR SER THR SEQRES 14 D 229 GLU MET ASP ASP ILE ILE ASN VAL PHE GLU SER LEU MET SEQRES 15 D 229 ASN LYS LEU ALA GLU SER MET SER ASP LYS GLU LEU GLU SEQRES 16 D 229 GLN VAL LYS GLN VAL PHE LEU GLU SER CYS ILE HIS GLU SEQRES 17 D 229 ARG ARG PHE PHE ASN MET ALA MET THR LEU GLU GLN TRP SEQRES 18 D 229 GLU PHE GLY GLY LYS VAL ASN ASP MODRES 4FN6 CME A 137 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4FN6 CME B 137 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4FN6 CME C 137 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4FN6 CME D 137 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 137 10 HET CME B 137 10 HET CME C 137 10 HET CME D 137 10 HET ACT A 301 4 HET ACT A 302 4 HET GOL A 303 6 HET ACT B 301 4 HET ACT B 302 4 HET GOL B 303 6 HET GOL C 301 6 HET GOL C 302 6 HET ACT C 303 4 HET ACT C 304 4 HET ACT D 301 4 HET ACT D 302 4 HET ACT D 303 4 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM ACT ACETATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 CME 4(C5 H11 N O3 S2) FORMUL 5 ACT 9(C2 H3 O2 1-) FORMUL 7 GOL 4(C3 H8 O3) FORMUL 18 HOH *81(H2 O) HELIX 1 1 GLU A 2 ASP A 21 1 20 HELIX 2 2 ASP A 21 GLY A 30 1 10 HELIX 3 3 GLN A 33 TYR A 47 1 15 HELIX 4 4 TYR A 47 ILE A 59 1 13 HELIX 5 5 SER A 64 GLU A 80 1 17 HELIX 6 6 VAL A 83 GLY A 94 1 12 HELIX 7 7 SER A 96 THR A 103 1 8 HELIX 8 8 PRO A 107 ARG A 124 1 18 HELIX 9 9 ALA A 127 ALA A 135 1 9 HELIX 10 10 ALA A 135 SER A 150 1 16 HELIX 11 11 ASP A 159 SER A 168 1 10 HELIX 12 12 MET A 171 GLU A 187 1 17 HELIX 13 13 SER A 190 THR A 217 1 28 HELIX 14 14 GLU B 2 ASP B 21 1 20 HELIX 15 15 ASP B 21 LEU B 29 1 9 HELIX 16 16 GLN B 33 TYR B 47 1 15 HELIX 17 17 TYR B 47 LEU B 58 1 12 HELIX 18 18 SER B 64 GLY B 81 1 18 HELIX 19 19 VAL B 83 GLY B 94 1 12 HELIX 20 20 SER B 96 ILE B 101 1 6 HELIX 21 21 PRO B 107 ARG B 124 1 18 HELIX 22 22 ASN B 126 ALA B 135 1 10 HELIX 23 23 CME B 137 SER B 150 1 14 HELIX 24 24 THR B 160 SER B 168 1 9 HELIX 25 25 MET B 171 GLU B 187 1 17 HELIX 26 26 SER B 190 THR B 217 1 28 HELIX 27 27 GLU C 2 ALA C 11 1 10 HELIX 28 28 ALA C 11 ASP C 21 1 11 HELIX 29 29 ASP C 21 GLY C 30 1 10 HELIX 30 30 GLN C 33 TYR C 47 1 15 HELIX 31 31 TYR C 47 ILE C 59 1 13 HELIX 32 32 SER C 64 GLU C 80 1 17 HELIX 33 33 VAL C 83 GLY C 94 1 12 HELIX 34 34 SER C 96 ILE C 101 1 6 HELIX 35 35 PRO C 107 ARG C 124 1 18 HELIX 36 36 ALA C 127 ALA C 135 1 9 HELIX 37 37 ALA C 135 SER C 150 1 16 HELIX 38 38 THR C 160 SER C 168 1 9 HELIX 39 39 MET C 171 GLU C 187 1 17 HELIX 40 40 SER C 190 THR C 217 1 28 HELIX 41 41 GLU D 2 ALA D 11 1 10 HELIX 42 42 ALA D 11 GLU D 20 1 10 HELIX 43 43 ASP D 21 GLY D 30 1 10 HELIX 44 44 GLN D 33 TYR D 47 1 15 HELIX 45 45 TYR D 47 ILE D 59 1 13 HELIX 46 46 PRO D 60 MET D 62 5 3 HELIX 47 47 SER D 64 GLU D 80 1 17 HELIX 48 48 VAL D 83 GLY D 94 1 12 HELIX 49 49 SER D 96 ILE D 101 1 6 HELIX 50 50 PRO D 107 ARG D 124 1 18 HELIX 51 51 ALA D 127 ALA D 135 1 9 HELIX 52 52 ALA D 135 SER D 150 1 16 HELIX 53 53 THR D 160 GLU D 170 1 11 HELIX 54 54 MET D 171 ALA D 186 1 16 HELIX 55 55 SER D 190 LEU D 218 1 29 LINK C PRO A 136 N CME A 137 1555 1555 1.33 LINK C CME A 137 N PRO A 138 1555 1555 1.33 LINK C PRO B 136 N CME B 137 1555 1555 1.33 LINK C CME B 137 N PRO B 138 1555 1555 1.33 LINK C PRO C 136 N CME C 137 1555 1555 1.32 LINK C CME C 137 N PRO C 138 1555 1555 1.35 LINK C PRO D 136 N CME D 137 1555 1555 1.32 LINK C CME D 137 N PRO D 138 1555 1555 1.33 CISPEP 1 CME D 137 PRO D 138 0 6.19 SITE 1 AC1 5 SER A 190 ASP A 191 HOH A 431 SER C 188 SITE 2 AC1 5 MET C 189 SITE 1 AC2 4 ASP A 44 TYR A 47 CME A 137 GLU A 208 SITE 1 AC3 4 ASP A 21 ASP A 22 ASN A 213 HOH A 423 SITE 1 AC4 4 LYS B 6 GLN B 9 ALA B 10 LYS B 198 SITE 1 AC5 1 ASP B 21 SITE 1 AC6 7 HIS B 122 SER B 123 GLU B 125 LYS C 61 SITE 2 AC6 7 ALA C 121 HIS C 122 ARG C 124 SITE 1 AC7 6 ASP C 44 PHE C 51 TYR C 113 CME C 137 SITE 2 AC7 6 TYR C 141 GLU C 208 SITE 1 AC8 1 TRP C 106 SITE 1 AC9 2 SER B 190 SER C 188 SITE 1 BC1 2 MET C 78 CME C 137 SITE 1 BC2 5 ASP D 44 PHE D 51 CME D 137 TYR D 141 SITE 2 BC2 5 GLU D 208 SITE 1 BC3 1 GLU D 157 SITE 1 BC4 3 HIS A 122 SER A 123 SER D 123 CRYST1 103.276 104.061 109.451 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009683 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009610 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009137 0.00000